Philip Scheltens

Philip Scheltens studied at the VU University Amsterdam, Netherlands, gaining his MD in 1984, and PhD in 1993.

He was appointed as Professor of Cognitive Neurology in 2002 and founded the Alzheimer Center at Amsterdam University Medical Centers in that same year, which he directed until 2022. Currently he is partner at EQT group and heads the Dementia Fund at EQT Life Sciences, that he started in 2020. He has been the (inter)national PI for over 35 studies, including phase 1-3 multicenter clinical trials.

He founded and led the Dutch National Plan against dementia and served as chair of the board until 2021. Philip served as co-editor-in-chief of Alzheimer’s Research & Therapy from 2013- 2022 and co-led various EU projects. He authored over 1100 peer reviewed papers and > 75 book chapters and co-edited several major text books.